IDEXX Laboratories Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 37/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 768.16.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
IDEXX Laboratories Inc's Score
Industry at a Glance
Industry Ranking
37 / 208
Overall Ranking
112 / 4592
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
16
analysts
Buy
Current Rating
768.158
Target Price
+8.70%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
IDEXX Laboratories Inc Highlights
StrengthsRisks
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 15.74% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 3.90B.
Overvalued
The company’s latest PE is 55.42, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 77.76M shares, decreasing 4.93% quarter-over-quarter.
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
Ticker SymbolIDXX
CompanyIDEXX Laboratories Inc
CEOEmerson (Andrew)
Websitehttps://www.idexx.com/
FAQs
What is the current price of IDEXX Laboratories Inc (IDXX)?
The current price of IDEXX Laboratories Inc (IDXX) is 701.315.
What is the symbol of IDEXX Laboratories Inc?
The ticker symbol of IDEXX Laboratories Inc is IDXX.
What is the 52-week high of IDEXX Laboratories Inc?
The 52-week high of IDEXX Laboratories Inc is 769.980.
What is the 52-week low of IDEXX Laboratories Inc?
The 52-week low of IDEXX Laboratories Inc is 356.140.
What is the market capitalization of IDEXX Laboratories Inc?
The market capitalization of IDEXX Laboratories Inc is 56.10B.
What is the net income of IDEXX Laboratories Inc?
The net income of IDEXX Laboratories Inc is 887.87M.
Is IDEXX Laboratories Inc (IDXX) currently rated as Buy, Hold, or Sell?
According to analysts, IDEXX Laboratories Inc (IDXX) has an overall rating of Buy, with a price target of 768.158.
What is the Earnings Per Share (EPS TTM) of IDEXX Laboratories Inc (IDXX)?
The Earnings Per Share (EPS TTM) of IDEXX Laboratories Inc (IDXX) is 12.706.